ANI Pharmaceuticals Launches Duloxetine Delayed-Release Capsules 20, 30 And 60 Mg, Generic Version Of Reference Listed Drug Cymbalta

ANI Pharmaceuticals, Inc. has launched Duloxetine Delayed-Release Capsules in 20, 30, and 60 mg, which are the generic version of Cymbalta. The U.S. annual sales for Duloxetine are approximately $247 million, according to August 2026 moving annual total (MAT) IQVIA data.